{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:14:40Z","timestamp":1773404080999,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":87,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BioMed Research International"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>Hepatic fibrosis is a progressive disease with serious clinical complications that arise from abnormal propagation and activation of multiple inflammatory pathways. Nilotinib is an oral tyrosine kinase inhibitor with antifibrotic activity. Mesenchymal stem cells (MSCs) are blank cells and can differentiate into specific cell types. They have the potential to repair and regenerate cells. MSCs have a special paracrine fashion where they produce special exosomes, microvesicles, and cytokines like IL\u20106, transforming growth factor\u2010beta (TGF\u2010<jats:italic>\u03b2<\/jats:italic>), and HGF as well as hepatic stellate cell suppressors. This paracrine fashion can decrease collagen deposition, enhance antifibrotic, anti\u2010inflammatory, and angiogenic activity in vitro and in vivo. In our study, the rat\u2019s hepatic stellate cells (HSCs) in addition to different normal cell lines were treated with Nilotinib alone and in combination with liver mesenchymal stem cells conditioned medium (LMSCs\u2010CM) for 24\u2009h. Mono and combined therapy antifibrotic and cytotoxicity effects were evaluated using different parameters including <jats:italic>\u03b1<\/jats:italic>\u2010SMA, cytochrome c, P53 expression, collagen deposition, DNA content, oxidative stress parameters, cell viability, and apoptosis by flow cytometry analysis. Our results showed that Nilotinib and LMSCs\u2010CM in combination had a significantly potent antifibrotic and anti\u2010inflammatory effect on activated hepatic stellate cells than Nilotinib alone; otherwise, this combination showed the best safety with minimal cytotoxicity on different normal cell lines.<\/jats:p>","DOI":"10.1155\/2021\/6678913","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T19:05:07Z","timestamp":1617044707000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5617-4726","authenticated-orcid":false,"given":"Ahmed","family":"Nabil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-0585","authenticated-orcid":false,"given":"Koichiro","family":"Uto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-7559","authenticated-orcid":false,"given":"Mohamed M.","family":"Elshemy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-0350","authenticated-orcid":false,"given":"Mitsuhiro","family":"Ebara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-8854","authenticated-orcid":false,"given":"Gamal","family":"Shiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"e_1_2_8_1_2","first-page":"361","article-title":"Molecular pathogenesis of liver fibrosis","volume":"120","author":"Brenner D. A.","year":"2009","journal-title":"Transactions of the American Clinical and Climatological Association"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.02.011"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1362104"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12286"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i3.742"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.030"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14115"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.02.020"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25986"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.3727\/000000007783465154"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6574010"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01682.x"},{"key":"e_1_2_8_13_2","first-page":"38","article-title":"Evaluation of antiproliferative activity of Trichosanthes dioica root against Ehrlich ascites carcinoma cells","volume":"4","author":"Bhattacharya S.","year":"2011","journal-title":"Academic Journal of Cancer Research"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/cb4007584"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-940-0:099"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6940"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(80)90165-7"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.2741\/887"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.4.548"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205169"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-105627"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.10.014"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.11.035"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.08.041"},{"key":"e_1_2_8_25_2","first-page":"1230","article-title":"Human umbilical cord mesenchymal stem cells and exosomes: bioactive ways of tissue injury repair","volume":"11","author":"Yin S.","year":"2019","journal-title":"American Journal of Translational Research"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00013.2007"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2011.10.012"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22236"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047559"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.248"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-078774"}],"container-title":["BioMed Research International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2021\/6678913.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2021\/6678913.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2021\/6678913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T16:11:59Z","timestamp":1735661519000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2021\/6678913"}},"subtitle":[],"editor":[{"given":"Vivekanand","family":"Vivekanand","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1155\/2021\/6678913"],"URL":"https:\/\/doi.org\/10.1155\/2021\/6678913","archive":["Portico"],"relation":{},"ISSN":["2314-6133","2314-6141"],"issn-type":[{"value":"2314-6133","type":"print"},{"value":"2314-6141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"2020-10-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"6678913"}}